New biosecurity centre to tackle pandemics and animal disease gets £1bn funding
The funding for the next phase of a biosecurity centre at Weybridge, Surrey, comes after warnings from the National Audit Office that the Government was not properly prepared for a major outbreak of animal disease.
Animal diseases such as bird flu, bluetongue and African swine fever can pose serious threats to England's farming sector, food security, and wildlife, and are a major and increasing risk to public health.
About 60% of all known human infectious diseases can be transmitted from animals to people, and three quarters of emerging infectious diseases originate in animals, officials warned.
The 'record' investment will complete the redevelopment of the crumbling animal science facilities at Weybridge, which the National Audit Office (NAO) recently warned was at 'very high' risk of site failure.
It aims to enhance detection, surveillance and control measures for high-risk animal diseases such as foot and mouth, officials said.
Environment Secretary Steve Reed said: 'The first role of any Government is national security.
'That is why we are making a record investment into the nation's biosecurity capabilities and, in turn, our national security, after years of chronic underfunding.
'Farmers and food producers will now be better protected from diseases, our food security strengthened, and public health better safeguarded against future pandemics.'
Jenny Stewart, senior science director at the Animal and Plant Health Agency, which runs the labs, said the funding was a 'vital milestone' in the delivery of the new facilities.
'Our scientists and specialists at Weybridge are at the heart of the UK's disease surveillance and response capability and provide a global centre of expertise.
'Investment on this scale will enable them to continue their critical work in modern, fit-for-purpose facilities, supported by the very latest technologies.'
The Government said work was already under way at the Weybridge site, with the first interim labs to support science ready in 2027 and 2028, and the national biosecurity centre due to be operational in 2033-34.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
27 minutes ago
- Daily Mail
Study pinpoints how long it takes to regain weight after stopping weight loss jabs - and it's quicker than you think
Blockbuster weight loss jabs relied on by millions not be the quick fix many believe them to be, as users pile on the pounds within just eight weeks of stopping treatment, experts have warned. More than a million people in the UK are now injecting themselves weekly with drugs such as Mounjaro and Wegovy—bought online or through private clinics—lured by promises of rapid results. Known collectively as GLP-1s, the weekly injections can see users lose up to a fifth of their body weight in as little as a year, upending the obesity treatment playbook. But now experts in metabolic medicine, from Peking University People's Hospital, Beijing, have warned that the results are likely to be short-lived if patients do not maintain a healthy lifestyle after coming off the jabs. Even those taking newer, more powerful jabs like Mounjaro were found to regain the weight once treatment was stopped. The researchers, led by Professors Xiaoling Cai and Lingong Ji, found that even those on trizeparide—the so-called 'King Kong' of weight loss jabs, regained almost half the weight they had previously lost after coming off the drug and switching to a placebo. Whilst the study, published in the journal BMC Medicine, didn't explain exactly why people pile the weight back on so fast, the researchers speculated it could be due to a phenomenon known as 'weight cycling.' This refers to the process of regaining weight after stopping treatment, and can be due to a number of factors. One potential reason for rapid weight gain after coming off the jabs could be due to hormonal changes in the gut. According to the researchers, previous studies with very low energy diets show that weight loss induces adverse hormonal changes in the gut that potentially affect weight regain after treatment. 'This adverse hormonal change in the gut causes an increase in hunger levels and urge to eat, which promotes weight regain,' Prof Cai explained. Other experts, such as Professor Susan Jebb, who was not involved in the study, have speculated the post-treatment weight gain could simply be because diets are hard. No self restraint is required when taking the drugs, so people don't have effective 'behavioural strategies in place' when they stop taking them. The injections trigger weight loss by mimicking the actions of a hormone released in the gut after eating called GLP-1. As well as signalling to the pancreas to make more insulin, this hormone feeds back to the brain, stopping users from overeating. The findings could raise issues for both the Government, which plans to roll out a new £85million weight loss jab trial involving tens of thousands of people offered the drug, and manufacturers such as Eli Lily who announced last week they are increasing the price of their products in the UK. Despite many being eager to take the drugs, the revolutionary jabs are not without side effects, and as such currently only patients with a body mass index (BMI) over 30 and at least one weight-related health problem can qualify for treatment. UK law forbids the sale of drugs such as Wegovy without a prescription from a medical professional. Common side-effects include nausea, constipation and diarrhoea after taking the medication and many users have spoken out about struggling to keep the weight off after stopping the medication. Some doctors have also warned they are seeing patients with serious, life-threatening complications including seizures, bowel obstructions and inflammation of the pancreas, known as pancreatitis. Healthcare watchdog NICE currently advises that users should not be on the injections for more than two years. Tam Fry, chairman of the National Obesity Forum, added: 'It shouldn't surprise anyone if people regain weight having used GLP-1 drugs without seriously attempting to improve their lifestyle. 'Using GLP1-s is not the quick fix which many users believe it to be.'
Telegraph
an hour ago
- Telegraph
High street diagnostic centres opening at evenings and weekends
The NHS delivered more than 1.6 million more tests and scans from July 2024 to June 2025 and there were 218,463 people who had cancer ruled out or diagnosed within 28 days, the Department of Health said. Improved performance on the faster diagnosis standard means that nearly 97,000 more people had cancer diagnosed or ruled out within 28 days between July 2024 and June 2025, compared to the same period last year. At Oldham CDC in Greater Manchester, extended opening hours have cut lung cancer diagnosis times from 42 days to just 18.8 days, while Queen Victoria Hospital CDC in East Grinstead, West Sussex, is recording five times more respiratory patient interactions per session, with 92 per cent avoiding the need for hospital outpatient appointments. Patients can be referred to CDCs through their GP or hospital-based clinical teams. Mr Streeting said the Government's 10-year health plan is 'revolutionising how healthcare works' and the measures are helping to bring care closer to the community. Prof Meghana Pandit, NHS England national medical director, said: 'We know people are living incredibly busy lives and it's vital NHS care reflects that. 'The services provided by community diagnostics centres enable people to receive the all-clear or a diagnosis at a time and location that suits them, whether before a school drop off or after a work shift, and extending their opening hours means more people are being seen more quickly.' CDCs can provide a range of tests including MRI and CT scans, echocardiography and phlebotomy services. Wayne Rowlands, who visited the Norfolk and Norwich University Hospital Community Diagnostic Centre for an emergency CT scan, described it as a 'pleasant experience' in a setting that was 'very bright and not at all like a hospital'. The Government's Plan for Change is backed by more than £6bn of additional capital investment to improve capacity for elective, diagnostic, and urgent care services over five years, with more than £600m capital funding committed for 2025-26 to transform diagnostic services. This includes funding up to five additional CDCs in 2025-26 and extending opening hours for all CDCs at evenings and at weekends. Laura Challinor, of the Blood Cancer UK charity, welcomed the move but said more must be done to tackle regional variation and speed up testing. She said: 'It's imperative that everyone affected by blood cancer can readily access the diagnostic tests and appointments they need. 'With blood cancer being the UK's third biggest cancer killer and survival lagging behind countries of similar wealth and health, doing all we can to turn that tide is critical.'
South Wales Guardian
5 hours ago
- South Wales Guardian
More checks, tests and scans to be offered out of hours at local health centres
Extending the opening hours for Community Diagnostic Centres (CDCs) is increasing access to health services and speeding up diagnosis for thousands of patients, according to the Department of Health and Social Care (DHSC) Some 7.2 million CDC tests and scans have been delivered since July 2024. Shopping centres, community hospitals and university campuses are among the venues closer to people's homes where the centres are based and open out of hours for health appointments. Health Secretary Wes Streeting said the Government is 'determined to offer healthcare that fits around working people's lives and not the other way around'. He added: 'From early morning MRI scans to late evening blood tests, we're meeting patients where they need it most by extending the operating hours for community diagnostic centres and putting patients first.' The NHS delivered more than 1.6 million more tests and scans from July 2024 to June 2025 and there were 218,463 people who had cancer ruled out or diagnosed within 28 days, the DHSC said. Improved performance on the faster diagnosis standard means that nearly 97,000 more people had cancer diagnosed or ruled out within 28 days between July 2024 and June 2025, compared to the same period last year. At Oldham CDC in Greater Manchester, extended opening hours have cut lung cancer diagnosis times from 42 days to just 18.8 days, while Queen Victoria Hospital CDC in East Grinstead, West Sussex, is recording five times more respiratory patient interactions per session, with 92% avoiding the need for hospital outpatient appointments. Patients can be referred to CDCs through their GP or hospital-based clinical teams. Mr Streeting said the Government's 10-year health plan is 'revolutionising how healthcare works' and the measures are helping to bring care closer to the community. Professor Meghana Pandit, NHS England national medical director, said: 'We know people are living incredibly busy lives and it's vital NHS care reflects that. 'The services provided by Community Diagnostics Centres enable people to receive the all-clear or a diagnosis at a time and location that suits them, whether before a school drop off or after a work shift, and extending their opening hours means more people are being seen more quickly.' CDCs can provide a range of tests including MRI and CT scans, echocardiography and phlebotomy services. Wayne Rowlands, who visited the Norfolk and Norwich University Hospital Community Diagnostic Centre for an emergency CT scan, described it as a 'pleasant experience' in a setting that was 'very bright and not at all like a hospital'. The Government's plan for change is backed by more than £6 billion of additional capital investment to improve capacity for elective, diagnostic, and urgent care services over five years, with more than £600 million capital funding committed for 2025/26 to transform diagnostic services. This includes funding up to five additional CDCs in 2025/26 and extending opening hours for all CDCs at evenings and at weekends. Laura Challinor from the Blood Cancer UK charity welcomed the move but said more must be done to tackle regional variation and speed up testing. She said: 'It's imperative that everyone affected by blood cancer can readily access the diagnostic tests and appointments they need. 'With blood cancer being the UK's third biggest cancer killer and survival lagging behind countries of similar wealth and health, doing all we can to turn that tide is critical.'
